Annex 1 and Environmental Monitoring Program – Implementation and Justification
Posted on August 17, 2022
Benoit Ramond, Head of Microbiology & Sterile Technology, Sanofi
The manufacture of pharmaceutical products, and more precisely sterile preparations, is subject to special requirements by different regulations including Pharmacopoeias as well as guidelines such as FDA with the Guidelines for Industry and European Commission GMP with Annex 1. Figure 1 shows the sc...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy















